Proactive COVID-19 testing
By identifying COVID-19 positive cases early on, particularly those that are asymtomatic, we can restrict further transmission of this deadly virus.
Integrated CMC Strategy for Small Molecule Development – CRO Perspective
Syngene’s 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies. As a result, the typical time from clinical candidate to regulatory filing is just 11 months.
Biologics Development and Manufacturing Services
Syngene offers end‑to‑end biologics services across a broad range of modalities and therapeutic areas, including mAbs, recombinant proteins, bispecifics, biosimilars, and antibody–drug conjugates (ADCs).
Dedicated R&D Centres – The Next Step In The Pharma Outsourcing Model
Syngene’s Dedicated R&D Centre is a unique business model where we set up a dedicated ring-fenced infrastructure with an exclusive team of scientific talent to support client projects.
Syngene’s Supply Chain Management Improves Efficiency
Syngene’s SCM team manages more than 1,000 vendors and 20,000 item codes in the SAP ERP system, enabling easy access and order placement.
Syngene Viral Testing Facility – Striving for Excellence
Syngene, is India’s first and only GLP-certified service provider for Viral Clearance and Safety Testing. Our laboratories are per the OECD rules covering countries such as USA and Japan.